Skip to main content
. 2014 Feb 13;14:87. doi: 10.1186/1471-2407-14-87

Table 4.

Analysis using the quintile version of EDI and Population Attributable Fraction in males between 1997 and 2009

Site   RR CI PAF a (%)
Prostate
Quintile 1
1.19
[1.09; 1.29]
9.6
 
Quintile 2
1.13
[1.04; 1.22]
 
 
Quintile 3
1.04
[0.96; 1.12]
 
 
Quintile 4
1.15
[1.06; 1.24]
 
 
Quintile 5
1
 
 
Lung
Quintile 1
1
 
9.9
 
Quintile 2
1.07
[0.97; 1.19]
 
 
Quintile 3
0.99
[0.88; 1.10]
 
 
Quintile 4
1.18
[1.06; 1.31]
 
 
Quintile 5
1.44
[1.29; 1.61]
 
Lips-mouth-pharynx
Quintile 1
1
 
26.0
 
Quintile 2
1.23
[1.06; 1.43]
 
 
Quintile 3
1.20
[1.03; 1.39]
 
 
Quintile 4
1.54
[1.34; 1.78]
 
 
Quintile 5
2.05
[1.77; 2.05]
 
Bladder
Quintile 1
1
 
6.0
 
Quintile 2
1.10
[0.95; 1.27]
 
 
Quintile 3
0.93
[0.80; 1.09]
 
 
Quintile 4
1.51
[0.99; 1.34]
 
 
Quintile 5
1.19
[1.01; 1.40]
 
Liver
Quintile 1
1
 
6.9
 
Quintile 2
1.04
[0.85; 1.27]
 
 
Quintile 3
0.93
[0.75; 1.14]
 
 
Quintile 4
1.14
[0.94; 1.38]
 
 
Quintile 5
1.40
[1.15; 1.71]
 
Esophagus
Quintile 1
1
 
19.6
 
Quintile 2
1.30
[1.05; 1.63]
 
 
Quintile 3
1.17
[0.95; 1.47]
 
 
Quintile 4
1.24
[1.01; 1.54]
 
 
Quintile 5
1.67
[1.34; 2.11]
 
Unknown primary sites
Quintile 1
1
 
9.7
 
Quintile 2
0.99
[0.79; 1.26]
 
 
Quintile 3
1.12
[0.89; 1.41]
 
 
Quintile 4
1.18
[0.95; 1.47]
 
 
Quintile 5
1.13
[1.03; 1.65]
 
Larynx
Quintile 1
1
 
23.2
 
Quintile 2
1.05
[0.81; 1.35]
 
 
Quintile 3
1.24
[0.98; 1.58]
 
 
Quintile 4
1.54
[1.22; 1.95]
 
 
Quintile 5
1.91
[1.49; 2.45]
 
Melanoma
Quintile 1
1.37
[1.07; 1.77]
14.0
 
Quintile 2
1.16
[0.89; 1.49]
 
 
Quintile 3
1.06
[0.82; 1.37]
 
 
Quintile 4
1.18
[0.92; 1.50]
 
 
Quintile 5
1
 
 
Central nervous system
Quintile 1
1
 
9.4
 
Quintile 2
1.05
[0.81; 1.35]
 
 
Quintile 3
1.16
[0.91; 1.47]
 
 
Quintile 4
1.15
[0.90; 1.44]
 
 
Quintile 5
1.19
[0.93; 1.54]
 
Gall-bladder
Quintile 1
1
 
30.1
 
Quintile 2
1.59
[0.94; 2.80]
 
 
Quintile 3
1.32
[0.77; 2.27]
 
 
Quintile 4
1.31
[0.90; 2.60]
 
  Quintile 5 1.88 [1.11; 3.24]  

aPAF calculated with quintile 1 as reference except for prostate cancer and melanoma.